Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
JCI Insight
|
April 19, 2022
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype
Felix Orben, Katharina Lankes, Christian Schneeweis, et al.
Targeted Oncology
|
February 28, 2023
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich<sup>LMU</sup> Molecular Tumor Board
Klara Dorman, Danmei Zhang, Kathrin Heinrich, et al.
Journal of Cancer Research and Clinical Oncology
|
October 1, 2024
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)
David Witte, Ina Pretzell, Timm M Reissig, et al.
Gastroenterology
|
July 23, 2022
Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis
Ujjwal M Mahajan, Bettina Oehrle, Simon Sirtl, et al.
Gastroenterology
|
May 8, 2026
Neutrophil-Driven Trogocytosis in PDAC Liver Metastases Restrains Immunosuppressive Macrophage Polarization and Limits Metastatic Progression
Larissa Belz, Dominic van den Heuvel, Badr Kilani, et al.
Gastroenterology
|
August 10, 2018
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma
Ujjwal Mukund Mahajan, Eno Langhoff, Elisabetta Goni, et al.
JNCI Cancer Spectrum
|
April 17, 2020
Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer
Ujjwal M Mahajan, Elisabetta Goni, Enno Langhoff, et al.
Gut
|
December 21, 2023
Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis
Christoph Ammer-Herrmenau, Kai L Antweiler, Thomas Asendorf, et al.
Targeted Oncology
|
August 18, 2023
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich
Danmei Zhang, Klara Dorman, Kathrin Heinrich, et al.
The Lancet. Gastroenterology & Hepatology
|
May 19, 2025
Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study
Ujjwal M Mahajan, Bettina Oehrle, Elisabetta Goni, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
JCI Insight
|
April 19, 2022
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype
Felix Orben, Katharina Lankes, Christian Schneeweis, et al.
Targeted Oncology
|
February 28, 2023
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich<sup>LMU</sup> Molecular Tumor Board
Klara Dorman, Danmei Zhang, Kathrin Heinrich, et al.
Journal of Cancer Research and Clinical Oncology
|
October 1, 2024
Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123)
David Witte, Ina Pretzell, Timm M Reissig, et al.
Gastroenterology
|
July 23, 2022
Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis
Ujjwal M Mahajan, Bettina Oehrle, Simon Sirtl, et al.
Gastroenterology
|
May 8, 2026
Neutrophil-Driven Trogocytosis in PDAC Liver Metastases Restrains Immunosuppressive Macrophage Polarization and Limits Metastatic Progression
Larissa Belz, Dominic van den Heuvel, Badr Kilani, et al.
Gastroenterology
|
August 10, 2018
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma
Ujjwal Mukund Mahajan, Eno Langhoff, Elisabetta Goni, et al.
JNCI Cancer Spectrum
|
April 17, 2020
Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer
Ujjwal M Mahajan, Elisabetta Goni, Enno Langhoff, et al.
Gut
|
December 21, 2023
Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis
Christoph Ammer-Herrmenau, Kai L Antweiler, Thomas Asendorf, et al.
Targeted Oncology
|
August 18, 2023
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich
Danmei Zhang, Klara Dorman, Kathrin Heinrich, et al.
The Lancet. Gastroenterology & Hepatology
|
May 19, 2025
Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study
Ujjwal M Mahajan, Bettina Oehrle, Elisabetta Goni, et al.
Page
of 10